Top compounds associated with response to NOG


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.031 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC -0.061 0.4
mRNA A-770041 GDSC1000 pan-cancer AAC -0.04 0.4
mRNA Y-39983 GDSC1000 pan-cancer AAC 0.025 0.4
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.024 0.4
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.025 0.4
Download CSV